80
Participants
Start Date
July 31, 2002
Primary Completion Date
June 30, 2006
Study Completion Date
July 31, 2007
IL13-PE38QQR
targeted fusion protein therapy
surgery
University Hospital Eppendorf, Hamburg
University Hospital Kiel, Department of Neurosurgery, Kiel
Cleveland Clinic Foundation, Cleveland
Chaim Sheba Medical Center, Tel Litwinsky
Sourasky Medical Center, Tel Aviv
University of Colorado Health Sciences Center, Denver
Lead Sponsor
INSYS Therapeutics Inc
INDUSTRY